VITAMIN B-12 (2137)

Compound Details

NameVITAMIN B-12
Compound class35013
Compound codeVITAMIN

Summary

Compound class: 35013

Experiments: 95

View Experiments

Experiments (95)

Filters
Worktypes (39)
30
24
16
14
12
12
10
10
8
8
8
6
5
4
4
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (13)
4
3
1
1
1
1
1
1
1
1
1
1
78
No match
Compounds (134)
95
12
11
10
8
6
6
5
5
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Organisms (89)
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
95 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)
980330
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
329906
SEPARATION OFPHARMACEUTICAL ANALYSIS OFQUANTITATIVE DATA REPORTEDTLC DATA REPORTED
Empty organism
319937
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Artemia salina (ARTEMIIDAE)
319205
STABILITY STUDIES OFPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
Empty organism
496556
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
621353
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDYREVIEW OF
Eubacterium limosum (CORYNEFORM ACTINOMYCETE)
496636
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Pseudomonas denitrificans (PSEUDOMONADACEAE)
319027
COMPLETE SYNTHESIS REPORTEDREVIEW OF
Empty organism
1166355
PHARMACOLOGY OF COMPOUND - IN HUMANS
FOOD USE
Empty organism
574439
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
131780
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Escherichia coli (ENTEROBACTERIACEAE)
318605
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIFIBRINOLYTIC ACTIVITY
Empty organism
319198
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYRADIOIMMUNOASSAY USEDREVIEW OF
Empty organism
323339
PARTIAL SYNTHESIS OF
Empty organism
325864
PHARMACEUTICAL FORMULATION OFREVIEW OF
Empty organism
405046
PHARMACOLOGY OF COMPOUND - IN HUMANS
GRAS STATUS
Empty organism
319187
LIQUID-LIQUID SEPARATION MARKER CODEPATENT DESCRIBED
Empty organism
319188
TLC DATA REPORTED
Empty organism
407184
BIOSYNTHESISIDENTIFICATION OF
Propionibacterium shermanii (LACTOBACILLACEAE)
521244
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Pseudomonas denitrificans (PSEUDOMONADACEAE)
360784
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Pseudomonas denitrificans (PSEUDOMONADACEAE)
321039
BIOSYNTHESIS
Propionibacterium shermanii (LACTOBACILLACEAE)
483526
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANALGESIC ACTIVITY
Empty organism
876930
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eubacterium limosum (CORYNEFORM ACTINOMYCETE)
855618
IDENTIFICATION OF
Halopithys incurvus (RHODOMELACEAE)
921467
QUANTITATIVE DATAIDENTIFICATION OF
Corallina rubens (CORALLINACEAE)
252482
ISOLATION AND IDENTIFICATION OF
Spirulina species (OSCILLATORIACEAE)
319182
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Empty organism
320942
COMPLETE SYNTHESIS REPORTEDREVIEW OF
Empty organism
489909
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Empty organism
326278
STABILITY STUDIES OFPHARMACEUTICAL FORMULATION OF
Empty organism
982609
PRESENT IN (REVIEW)REVIEW OF
Panax ginseng (ARALIACEAE)
426776
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
331225
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Actinomyces nigrescens (ACTINOMYCETACEAE)
319179
BIOSYNTHESISREVIEW OF
Empty organism
321157
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Empty organism
340166
QUANTITATIVE DATAIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Klebsiella species (ENTEROBACTERIACEAE)
1047186
CMR SPECTRUM REPORTED
Empty organism
1278871
QUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Chlorella pyrenoidosa (CHLORELLACEAE)
408548
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSCARCINOGENIC DATA (MARKER CODE)
COCARCINOGENIC ACTIVITY
Empty organism
325411
ISOLATION AND IDENTIFICATION OF
Pseudomonas species (PSEUDOMONADACEAE)
802328
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDYREVIEW OF
Propionibacterium shermanii (LACTOBACILLACEAE)
482945
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
321050
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Propionibacterium freudenreichii (LACTOBACILLACEAE)
1195747
PRESENT IN (REVIEW)REVIEW OF
Angelica sinensis (APIACEAE)
509891
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
341111
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Empty organism
818914
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
483527
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Empty organism
854233
QUANTITATIVE DATAIDENTIFICATION OF
Boletus edulis (BOLETACEAE)
512799
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Pseudomonas denitrificans (PSEUDOMONADACEAE)
319186
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDREVIEW OF
Empty organism
318772
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Empty organism
1026136
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
318606
PHARMACOLOGY OF COMPOUND - IN VIVO
COAGULANT ACTIVITY
Empty organism
489910
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Empty organism
329376
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Empty organism
889470
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
321595
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Empty organism
991682
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
489908
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Empty organism
613924
BIOSYNTHESISIDENTIFICATION OF
Propionibacterium shermanii (LACTOBACILLACEAE)
252483
PHARMACOLOGY OF COMPOUND - IN VITRO
CHEMILUMINESCENCE INHIBITION
Spirulina species (OSCILLATORIACEAE)
715856
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Pleurochrysis carterae (TO BE DETERMINED)
1052719
RADIOIMMUNOASSAY USEDREVIEW OF
Empty organism
1005282
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Clostridium tetanomorphum (BACILLACEAE)
454595
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
68918
PHARMACOLOGY OF COMPOUND - IN HUMANS
PSORIASIS TREATMENT
Empty organism
408545
BIOSYNTHESISIDENTIFICATION OF
Propionibacterium shermanii (LACTOBACILLACEAE)
978849
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
854232
QUANTITATIVE DATAIDENTIFICATION OF
Stropharia rugosoannulata (STROPHARIACEAE)
1004820
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pseudonocardia methanolignica (NOCARDIACEAE)
393536
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTED
Empty organism
7778
PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSEFFECTS ON PLANT GROWTH MARKER CODE
PLANT BIOSYNTHESIS INHIBITOR
Empty organism
330098
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Empty organism
454594
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
340168
QUANTITATIVE DATAIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Klebsiella species (ENTEROBACTERIACEAE)
319191
PHARMACOKINETIC/BIOAVAILABITY STUDYPREPARATION OF DERIVATIVES OF
Empty organism
325044
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYREVIEW OF
Empty organism
984325
PHARMACOLOGY OF EXTRACT - IN VIVOIDENTIFICATION OFPATENT DESCRIBED
ANTITUMOR ACTIVITY
Symphytum officinale (BORAGINACEAE)
481391
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Eubacterium limosum (CORYNEFORM ACTINOMYCETE)
861924
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Clostridium tetanomorphum (BACILLACEAE)
319174
PURIFICATION OFWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYAFFINITY CHROMATOGRAPHY USEDREVIEW OF
Empty organism
319209
SYNTHESIS OF ANALOGSPREPARATION OF DERIVATIVES OF
Empty organism
325793
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION AND IDENTIFICATION OF
Propionibacterium shermanii (LACTOBACILLACEAE)
624256
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Propionibacterium shermanii (LACTOBACILLACEAE)
319538
COMPLETE SYNTHESIS REPORTEDREVIEW OF
Empty organism
832006
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Clostridium tetanomorphum (BACILLACEAE)
317072
MECHANISM OF ACTION STUDIED
Empty organism
328816
SEPARATION OFPHARMACEUTICAL ANALYSIS OFQUANTITATIVE DATA REPORTEDTLC DATA REPORTED
Empty organism
321538
STABILITY STUDIES OFPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
Empty organism
325521
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANS
ANOREXIC ACTIVITY
Empty organism
322832
SEPARATION OFPHARMACEUTICAL ANALYSIS OFTLC DATA REPORTED
Empty organism
321250
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Empty organism
1026135
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
Show SPARQL Queries (1)